Catalyst Wire Dossier Catalyst Wire Dossier

RLX030

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RLX030, covering 2014-08-05 to 2015-11-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia [Phase 2]

See pricing